VALLEY COTTAGE, New York, Sept. 25, 2017 -- FMI delivers key insights and presents a revised forecast of the global vital signs monitoring devices market for a 10 year period from 2017 to 2027 in an upcoming report titled “Vital Signs Monitoring Devices Market: Global Industry Analysis and Opportunity Assessment 2017–2027.” The global vital signs monitoring devices market is projected to expand at a healthy CAGR of 8.7% and 9.2% in terms of value and volume respectively during the forecast period, due to factors, regarding which FMI offers useful insights in detail in this report. The global vital signs monitoring devices market is expected to increase from US$ 4,147.6 Mn by the end of 2016 to US$ 10,323.1 Mn by 2027 end in terms of value; and from 35,636 units by the end of 2016 to 93,656 units by 2027 end in terms of volume.
Global Market Research Report Overview on Vital Signs Monitoring Devices @ https://www.futuremarketinsights.com/reports/vital-signs-monitoring-devices-market
Market Segmentation and Forecast
Based on product type, the market has been segmented into monitors, temperature measurement devices, blood pressure measurement devices and standalone pulse oximeters. The monitors segment is further classified into three sub-segments namely low acuity monitors, mid acuity monitors and high acuity monitors. Monitors segment is a high value and low volume segment, which held 41.2% share of the global vital signs monitoring devices market in 2016. The monitors segment is expected to expand at a significant CAGR over the forecast period. The temperature measurement devices segment is sub-segmented into liquid-filled thermometers, digital thermometers and infrared thermometers. Temperature measurement devices was the most dominant segment among all other sub-segments in terms of volume, which stood at 31,465 units in the global vital signs monitoring devices market in 2016. The blood pressure measurement devices segment has been sub-segmented into sphygmomanometers and automated blood pressure monitors. The standalone pulse oximeters segment is projected to be the fastest growing segment in the market owing to its growing adoption in home care settings.
View Report Table of Contents, Figures, and Tables@ https://www.futuremarketinsights.com/reports/vital-signs-monitoring-devices-market/toc
Market Dynamics
Growth of the global vital signs monitoring devices market is mainly driven by the increasing importance of vital signs monitoring devices in home care settings, the expanding application of vital signs monitoring devices in the sports industry and the surge in ambulatory surgical centres across various countries, which actively employ vital signs monitoring devices routinely. The global vital signs monitoring devices market is fairly fragmented and is prone to the usage of a large number of low quality products, which could hamper growth of the market. Also, high end, advanced vital signs monitoring devices are being adopted at a lower rate in the market, especially in the developing regions, which again is acting as a restraint for the global market growth.
The global vital signs monitoring devices market is fragmented with a few major players and several small players. This trend is expected to continue over the forecast period as well. This is attributed to the low production cost of products such as thermometers. The vital signs monitoring devices companies are engaged in increasing awareness about their products through various marketing activities that are carried out in end use segments such as hospitals, clinics, ambulatory surgical centres and home care settings. Innovation and technological advancements, with regard to software, are opening up a plethora of opportunities for the vital signs monitoring devices market players currently.
A Sample of this report is available upon request@ https://www.futuremarketinsights.com/reports/sample/rep-gb-410
This report covers trends driving growth of each segment and respective sub-segments and offers analysis and insights on the potential of the vital signs monitoring devices market in specific regions. North America is expected to dominate the vital signs monitoring devices market, accounting for around 39.5% share of the overall market by the end of 2017, and is anticipated to remain dominant till the end of 2027. North America and Western Europe collectively accounted for over 54.1% share of the global vital signs monitoring devices market in 2016.
Vendor Landscape
Key players in the global vital signs monitoring devices market include CAS Medical Systems, Inc., Koninklijke Philips N.V., General Electric Co., Masimo Corporation, Mindray Medical International Limited, Medtronic, Inc., Nihon Kohden Corporation, Smiths Group plc, Dragerwerk AG & Co. KGaA, SunTech Medical, Inc., Spacelabs Healthcare, Inc. and ContecMedical Systems Co., Ltd. Market participants are focussed on new product development and approvals while expanding into emerging markets.
Buy Submersible Vital Signs Monitoring Devices Market Report@ https://www.futuremarketinsights.com/checkout/410
About Us
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.
Future Market Insights 616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 F: +1-845-579-5705 T (UK): +44(0)20-7692-8790 Sales: [email protected] Website: http://www.futuremarketinsights.com


Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge 



